CUE-102
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CUE-102, covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: CUE-102 in Recurrent Glioblastoma [Phase 1]
1 regulatory and trial event tracked for CUE-102, covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: CUE-102 in Recurrent Glioblastoma [Phase 1]